Sagimet Biosciences Inc (SGMT)
4.97
-0.10
(-1.97%)
USD |
NASDAQ |
Dec 20, 16:00
5.22
+0.25
(+5.03%)
After-Hours: 20:00
Sagimet Biosciences Total Liabilities (Quarterly): 4.092M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 296.11M |
| Y-mAbs Therapeutics Inc | 28.49M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 174.78M |
| Shareholders Equity (Quarterly) | 170.68M |